Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101412677A reveals a green nitration method using WO3/ZrO2 catalyst. This process offers high para-selectivity and reduced waste for reliable supply chains.
Patent CN102517361A details lipase-catalyzed arbutin synthesis offering mild conditions and high purity for reliable cosmetic ingredient supply chains.
Patent CN117089533A details novel carbonyl reductase mutants enabling cost reduction in chiral alcohol manufacturing with high stereoselectivity and supply reliability.
Patent CN114686451A discloses amine dehydrogenase mutants for high-yield production. Offers cost reduction in pharma intermediate manufacturing with >99% ee.
Patent CN104480181A reveals enzymatic D-7-ACA synthesis offering high purity and yield. This process enables cost reduction in pharmaceutical intermediates manufacturing and supply chain stability.
Patent CN103145630A details a green synthesis method for quinoxalines using water and recyclable ionic liquids, offering significant cost and environmental advantages for pharmaceutical intermediates.
Patent CN118546082B details a Cu-catalyzed co-production method offering significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN103555807B reveals one-step enzymatic route for 7-ACA. Offers high purity, reduced waste, and cost-effective supply chain solutions for global buyers.
Novel recombinant E. coli route for D-HPG production offers cost reduction in API intermediate manufacturing and enhanced supply chain reliability for global pharmaceutical partners.
Patent CN116515782A reveals a novel amine dehydrogenase mutant for high-purity chiral amine alcohol production, offering significant cost and safety advantages.
Patent CN110655494A details a novel ionic liquid-catalyzed route for triazinone. Achieves 92.4% yield with reduced waste, offering cost-effective agrochemical intermediate manufacturing.
Patent CN108949736B reveals a novel PGA mutant for cephradine synthesis, offering superior Vs/Vh ratios and reduced hydrolysis for efficient API manufacturing.
Patent CN118895266A reveals enzymatic synthesis of L-2-aminobutyric acid. Achieve >99% conversion with reduced environmental impact for levetiracetam production.
Patent CN110551771A reveals green enzymatic synthesis using 1,3-butanediol. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN105153041A details high-yield 5-flucytosine synthesis. Reduces waste and cost for reliable API supplier partnerships globally. Enhances supply chain stability.
Novel catalytic route for Vitamin K3 intermediate. High efficiency, safe, scalable. Reliable supplier for pharma intermediates.
Patent CN101870687A reveals safer phase-transfer catalysis for fluoroethylene carbonate production ensuring supply chain stability and cost efficiency for battery manufacturers.
Patent CN104328150B reveals continuous enzymatic synthesis. High yield, reduced cost, reliable supply chain for pharmaceutical intermediates manufacturing.
Patent CN108610253B details a green one-step Suzuki coupling for Flubensalicylic acid. Achieve 98.37% yield with ligand-free palladium catalysis for cost-effective manufacturing.
Efficient asymmetric Michael addition for pharmaceutical intermediates using novel Ru-diamine complexes. Reduces cost and improves purity for API manufacturing.